NCT05777785

A Novel Device for the Management of ADHD

A Pilot Study to Assess the Efficacy and Safety of a Novel Device (VIZO Glasses) in the Management of ADHD in Adults

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 108 (actual)
• Sponsor: VIZO Specs Ltd · Industry
• Sex: All
• Age: 18 Years – 40 Years
• Healthy volunteers: Not accepted

Summary

This is a 2-months study, where eligible ADHD adult participants will be provided with personalized VIZO glasses.

Detailed description

This study was designed as a pilot single-center, open-label study of 2 months treatment. Following the enrollment, the participants will go through an adjustment process where they will be fitted with a personalized pair of VIZO Glasses. The participants will be instructed to wear the glasses throughout the day for two months. A follow-up visit at the end of the 2-month treatment will be conducted to assess the efficacy of VIZO Glasses on managing ADHD symptoms, using the Conners Continuous Performance Test-3, the Adult ADHD Self-Report Scale (ASRS), Behavior Rating Inventory of Executive Function Adults (BRIEF-A), and Clinical Global Impression-Improvement (CGI-I) .

Conditions

• ADHD

Interventions

Type	Name	Description
DEVICE	VIZO Glasses	Eyeglasses with personalized peripheral retinal stimuli

Timeline

• Start date: 2022-04-01
• Primary completion: 2023-03-01
• Completion: 2023-03-26
• First posted: 2023-03-21
• Last updated: 2025-03-25
• Results posted: 2025-03-25

Locations

1 site across 1 country: Israel